Answers are grounded in this paper and cite their sources.
Case report demonstrates fenofibrate-induced rhabdomyolysis following ten days of treatment in undiagnosed hypothyroidism, highlighting the clinical risk of severe drug-induced muscle injury.
Fenofibrate induced rhabdomyolysis is not very common event. We present a case of muscle pain and generalized weakness following administration of fenofibrate for 10 days in undiagnosed hypothyroidism. Patient gradually improved after stopping the drug. As per our knowledge, this is probably the first case report of fenofibrate induced rhabdomyolysis from Nepal.
No takes yet. Share an insight, caveat, or question.
Shahi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: